Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Taiwan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20212
20223
20234
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
United Therapeutics2
Viatris Innovation GmbH2
ACADIA Pharmaceuticals Inc.1
Alnylam Pharmaceuticals1
AstraZeneca1
Celldex Therapeutics1
Eli Lilly and Company1
Sanofi1
Sarepta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases3
Lupus Erythematosus, Systemic3
Immune System Diseases2
Amyloidosis1
Autoimmune Diseases1
Cardiomyopathies1
Cardiovascular Diseases1
Chronic Urticaria1
Dermatitis, Atopic1
Dermatomyositis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.